抗うつ薬の世界市場:販売動向2018

【英語タイトル】Global Antidepressant Drugs Sales Market Report 2018

QYResearchが出版した調査資料(QYR80700922)・商品コード:QYR80700922
・発行会社(調査会社):QYResearch
・発行日:2018年10月
・ページ数:105
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、抗うつ薬の世界市場について調査・分析し、抗うつ薬のメーカー別販売量、市場シェア分析、種類別販売分析(大鬱病性障害、強迫神経症、全般性不安障害、パニック障害、その他)、用途別販売分析(三環系抗うつ薬、選択的セロトニン再取り込み阻害剤、セロトニン-ノルエピネフリン再取り込み阻害剤、モノアミンオキシダーゼ阻害剤、セロトニンアンタゴニスト・再取り込み阻害剤、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、抗うつ薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・抗うつ薬市場概要
・抗うつ薬のメーカー別販売量・メーカー別シェア
・抗うつ薬の世界市場:種類別販売量(大鬱病性障害、強迫神経症、全般性不安障害、パニック障害、その他)
・抗うつ薬の世界市場:用途別販売量(三環系抗うつ薬、選択的セロトニン再取り込み阻害剤、セロトニン-ノルエピネフリン再取り込み阻害剤、モノアミンオキシダーゼ阻害剤、セロトニンアンタゴニスト・再取り込み阻害剤、その他)
・抗うつ薬の世界市場:地域別販売量・市場シェア
・抗うつ薬の米国市場規模
・抗うつ薬の中国市場規模
・抗うつ薬の欧州市場規模
・抗うつ薬の日本市場規模
・抗うつ薬の東南アジア市場規模
・抗うつ薬のインド市場規模
・抗うつ薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・抗うつ薬のコスト分析・価格動向
・抗うつ薬の産業チェーン(サプライチェーン分析)
・抗うつ薬のマーケティング戦略・販売チャネル、流通業者
・抗うつ薬市場への影響要因分析
・抗うつ薬の世界市場予測
・抗うつ薬の米国市場予測
・抗うつ薬の中国市場予測
・抗うつ薬の欧州市場予測
・抗うつ薬の日本市場予測
・抗うつ薬の東南アジア市場予測
・抗うつ薬のインド市場予測
・抗うつ薬の種類別世界市場予測(大鬱病性障害、強迫神経症、全般性不安障害、パニック障害、その他)
・抗うつ薬の用途別世界市場予測(三環系抗うつ薬、選択的セロトニン再取り込み阻害剤、セロトニン-ノルエピネフリン再取り込み阻害剤、モノアミンオキシダーゼ阻害剤、セロトニンアンタゴニスト・再取り込み阻害剤、その他)
...
【レポートの概要】

This report studies the global Antidepressant Drugs market status and forecast, categorizes the global Antidepressant Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. Antidepressants help maintain balance of various hormones and chemicals in the brain, which helps in the treatment of depression.
The global Antidepressant Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Alkermes
Allergan
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Lundbeck
Merck
Pfizer
Teva
Takeda

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-norepinephrine reuptake Inhibitors
Monoamine oxidase inhibitors
Serotonin antagonist and reuptake inhibitors
Others

The study objectives of this report are:
To analyze and study the global Antidepressant Drugs sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Antidepressant Drugs players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antidepressant Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Antidepressant Drugs Manufacturers
Antidepressant Drugs Distributors/Traders/Wholesalers
Antidepressant Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Antidepressant Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Antidepressant Drugs Sales Market Report 2018
1 Antidepressant Drugs Market Overview
1.1 Product Overview and Scope of Antidepressant Drugs
1.2 Classification of Antidepressant Drugs by Product Category
1.2.1 Global Antidepressant Drugs Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Antidepressant Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Major Depressive Disorder
1.2.4 Obsessive-Compulsive Disorder
1.2.5 Generalized Anxiety Disorder
1.2.6 Panic Disorder
1.2.7 Others
1.3 Global Antidepressant Drugs Market by Application/End Users
1.3.1 Global Antidepressant Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Tricyclic Antidepressants
1.3.2 Selective Serotonin Reuptake Inhibitors
1.3.3 Serotonin-norepinephrine reuptake Inhibitors
1.3.4 Monoamine oxidase inhibitors
1.3.5 Serotonin antagonist and reuptake inhibitors
1.3.6 Others
1.4 Global Antidepressant Drugs Market by Region
1.4.1 Global Antidepressant Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Antidepressant Drugs Status and Prospect (2013-2025)
1.4.3 Europe Antidepressant Drugs Status and Prospect (2013-2025)
1.4.4 China Antidepressant Drugs Status and Prospect (2013-2025)
1.4.5 Japan Antidepressant Drugs Status and Prospect (2013-2025)
1.4.6 Southeast Asia Antidepressant Drugs Status and Prospect (2013-2025)
1.4.7 India Antidepressant Drugs Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Antidepressant Drugs (2013-2025)
1.5.1 Global Antidepressant Drugs Sales and Growth Rate (2013-2025)
1.5.2 Global Antidepressant Drugs Revenue and Growth Rate (2013-2025)

2 Global Antidepressant Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Antidepressant Drugs Market Competition by Players/Suppliers
2.1.1 Global Antidepressant Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Antidepressant Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Antidepressant Drugs (Volume and Value) by Type
2.2.1 Global Antidepressant Drugs Sales and Market Share by Type (2013-2018)
2.2.2 Global Antidepressant Drugs Revenue and Market Share by Type (2013-2018)
2.3 Global Antidepressant Drugs (Volume and Value) by Region
2.3.1 Global Antidepressant Drugs Sales and Market Share by Region (2013-2018)
2.3.2 Global Antidepressant Drugs Revenue and Market Share by Region (2013-2018)
2.4 Global Antidepressant Drugs (Volume) by Application

3 United States Antidepressant Drugs (Volume, Value and Sales Price)
3.1 United States Antidepressant Drugs Sales and Value (2013-2018)
3.1.1 United States Antidepressant Drugs Sales and Growth Rate (2013-2018)
3.1.2 United States Antidepressant Drugs Revenue and Growth Rate (2013-2018)
3.1.3 United States Antidepressant Drugs Sales Price Trend (2013-2018)
3.2 United States Antidepressant Drugs Sales Volume and Market Share by Players (2013-2018)
3.3 United States Antidepressant Drugs Sales Volume and Market Share by Type (2013-2018)
3.4 United States Antidepressant Drugs Sales Volume and Market Share by Application (2013-2018)

4 Europe Antidepressant Drugs (Volume, Value and Sales Price)
4.1 Europe Antidepressant Drugs Sales and Value (2013-2018)
4.1.1 Europe Antidepressant Drugs Sales and Growth Rate (2013-2018)
4.1.2 Europe Antidepressant Drugs Revenue and Growth Rate (2013-2018)
4.1.3 Europe Antidepressant Drugs Sales Price Trend (2013-2018)
4.2 Europe Antidepressant Drugs Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Antidepressant Drugs Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Antidepressant Drugs Sales Volume and Market Share by Application (2013-2018)

5 China Antidepressant Drugs (Volume, Value and Sales Price)
5.1 China Antidepressant Drugs Sales and Value (2013-2018)
5.1.1 China Antidepressant Drugs Sales and Growth Rate (2013-2018)
5.1.2 China Antidepressant Drugs Revenue and Growth Rate (2013-2018)
5.1.3 China Antidepressant Drugs Sales Price Trend (2013-2018)
5.2 China Antidepressant Drugs Sales Volume and Market Share by Players (2013-2018)
5.3 China Antidepressant Drugs Sales Volume and Market Share by Type (2013-2018)
5.4 China Antidepressant Drugs Sales Volume and Market Share by Application (2013-2018)

6 Japan Antidepressant Drugs (Volume, Value and Sales Price)
6.1 Japan Antidepressant Drugs Sales and Value (2013-2018)
6.1.1 Japan Antidepressant Drugs Sales and Growth Rate (2013-2018)
6.1.2 Japan Antidepressant Drugs Revenue and Growth Rate (2013-2018)
6.1.3 Japan Antidepressant Drugs Sales Price Trend (2013-2018)
6.2 Japan Antidepressant Drugs Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Antidepressant Drugs Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Antidepressant Drugs Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Antidepressant Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Antidepressant Drugs Sales and Value (2013-2018)
7.1.1 Southeast Asia Antidepressant Drugs Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Antidepressant Drugs Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Antidepressant Drugs Sales Price Trend (2013-2018)
7.2 Southeast Asia Antidepressant Drugs Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Antidepressant Drugs Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Antidepressant Drugs Sales Volume and Market Share by Application (2013-2018)

8 India Antidepressant Drugs (Volume, Value and Sales Price)
8.1 India Antidepressant Drugs Sales and Value (2013-2018)
8.1.1 India Antidepressant Drugs Sales and Growth Rate (2013-2018)
8.1.2 India Antidepressant Drugs Revenue and Growth Rate (2013-2018)
8.1.3 India Antidepressant Drugs Sales Price Trend (2013-2018)
8.2 India Antidepressant Drugs Sales Volume and Market Share by Players (2013-2018)
8.3 India Antidepressant Drugs Sales Volume and Market Share by Type (2013-2018)
8.4 India Antidepressant Drugs Sales Volume and Market Share by Application (2013-2018)

9 Global Antidepressant Drugs Players/Suppliers Profiles and Sales Data
9.1 Alkermes
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Antidepressant Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Alkermes Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Allergan
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Antidepressant Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Allergan Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Bristol Myers Squibb
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Antidepressant Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Bristol Myers Squibb Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Eli Lilly
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Antidepressant Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Eli Lilly Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 GlaxoSmithKline
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Antidepressant Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 GlaxoSmithKline Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Lundbeck
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Antidepressant Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Lundbeck Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Merck
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Antidepressant Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Merck Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Pfizer
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Antidepressant Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Pfizer Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Teva
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Antidepressant Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Teva Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Takeda
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Antidepressant Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Takeda Antidepressant Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview

10 Antidepressant Drugs Maufacturing Cost Analysis
10.1 Antidepressant Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Antidepressant Drugs
10.3 Manufacturing Process Analysis of Antidepressant Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Antidepressant Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Antidepressant Drugs Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Antidepressant Drugs Market Forecast (2018-2025)
14.1 Global Antidepressant Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Antidepressant Drugs Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Antidepressant Drugs Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Antidepressant Drugs Price and Trend Forecast (2018-2025)
14.2 Global Antidepressant Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Antidepressant Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Antidepressant Drugs Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Antidepressant Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Antidepressant Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Antidepressant Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Antidepressant Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Antidepressant Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Antidepressant Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Antidepressant Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Antidepressant Drugs Sales Forecast by Type (2018-2025)
14.3.2 Global Antidepressant Drugs Revenue Forecast by Type (2018-2025)
14.3.3 Global Antidepressant Drugs Price Forecast by Type (2018-2025)
14.4 Global Antidepressant Drugs Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Antidepressant Drugs
Figure Global Antidepressant Drugs Sales Volume Comparison (MT) by Type (2013-2025)
Figure Global Antidepressant Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Major Depressive Disorder Product Picture
Figure Obsessive-Compulsive Disorder Product Picture
Figure Generalized Anxiety Disorder Product Picture
Figure Panic Disorder Product Picture
Figure Others Product Picture
Figure Global Antidepressant Drugs Sales Comparison (MT) by Application (2013-2025)
Figure Global Sales Market Share of Antidepressant Drugs by Application in 2017
Figure Tricyclic Antidepressants Examples
Table Key Downstream Customer in Tricyclic Antidepressants
Figure Selective Serotonin Reuptake Inhibitors Examples
Table Key Downstream Customer in Selective Serotonin Reuptake Inhibitors
Figure Serotonin-norepinephrine reuptake Inhibitors Examples
Table Key Downstream Customer in Serotonin-norepinephrine reuptake Inhibitors
Figure Monoamine oxidase inhibitors Examples
Table Key Downstream Customer in Monoamine oxidase inhibitors
Figure Serotonin antagonist and reuptake inhibitors Examples
Table Key Downstream Customer in Serotonin antagonist and reuptake inhibitors
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Antidepressant Drugs Market Size (Million USD) by Regions (2013-2025)
Figure United States Antidepressant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Antidepressant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Antidepressant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Antidepressant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Antidepressant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Antidepressant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Antidepressant Drugs Sales Volume (MT) and Growth Rate (2013-2025)
Figure Global Antidepressant Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Antidepressant Drugs Sales Volume (MT) (2013-2018)
Table Global Antidepressant Drugs Sales (MT) of Key Players/Suppliers (2013-2018)
Table Global Antidepressant Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Antidepressant Drugs Sales Share by Players/Suppliers
Figure 2017 Antidepressant Drugs Sales Share by Players/Suppliers
Figure Global Antidepressant Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Antidepressant Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Antidepressant Drugs Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Antidepressant Drugs Revenue Share by Players
Table 2017 Global Antidepressant Drugs Revenue Share by Players
Table Global Antidepressant Drugs Sales (MT) and Market Share by Type (2013-2018)
Table Global Antidepressant Drugs Sales Share (MT) by Type (2013-2018)
Figure Sales Market Share of Antidepressant Drugs by Type (2013-2018)
Figure Global Antidepressant Drugs Sales Growth Rate by Type (2013-2018)
Table Global Antidepressant Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Antidepressant Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Antidepressant Drugs by Type (2013-2018)
Figure Global Antidepressant Drugs Revenue Growth Rate by Type (2013-2018)
Table Global Antidepressant Drugs Sales Volume (MT) and Market Share by Region (2013-2018)
Table Global Antidepressant Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Antidepressant Drugs by Region (2013-2018)
Figure Global Antidepressant Drugs Sales Growth Rate by Region in 2017
Table Global Antidepressant Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Antidepressant Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Antidepressant Drugs by Region (2013-2018)
Figure Global Antidepressant Drugs Revenue Growth Rate by Region in 2017
Table Global Antidepressant Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Antidepressant Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Antidepressant Drugs by Region (2013-2018)
Figure Global Antidepressant Drugs Revenue Market Share by Region in 2017
Table Global Antidepressant Drugs Sales Volume (MT) and Market Share by Application (2013-2018)
Table Global Antidepressant Drugs Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Antidepressant Drugs by Application (2013-2018)
Figure Global Antidepressant Drugs Sales Market Share by Application (2013-2018)
Figure United States Antidepressant Drugs Sales (MT) and Growth Rate (2013-2018)
Figure United States Antidepressant Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Antidepressant Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table United States Antidepressant Drugs Sales Volume (MT) by Players (2013-2018)
Table United States Antidepressant Drugs Sales Volume Market Share by Players (2013-2018)
Figure United States Antidepressant Drugs Sales Volume Market Share by Players in 2017
Table United States Antidepressant Drugs Sales Volume (MT) by Type (2013-2018)
Table United States Antidepressant Drugs Sales Volume Market Share by Type (2013-2018)
Figure United States Antidepressant Drugs Sales Volume Market Share by Type in 2017
Table United States Antidepressant Drugs Sales Volume (MT) by Application (2013-2018)
Table United States Antidepressant Drugs Sales Volume Market Share by Application (2013-2018)
Figure United States Antidepressant Drugs Sales Volume Market Share by Application in 2017
Figure Europe Antidepressant Drugs Sales (MT) and Growth Rate (2013-2018)
Figure Europe Antidepressant Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Antidepressant Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table Europe Antidepressant Drugs Sales Volume (MT) by Players (2013-2018)
Table Europe Antidepressant Drugs Sales Volume Market Share by Players (2013-2018)
Figure Europe Antidepressant Drugs Sales Volume Market Share by Players in 2017
Table Europe Antidepressant Drugs Sales Volume (MT) by Type (2013-2018)
Table Europe Antidepressant Drugs Sales Volume Market Share by Type (2013-2018)
Figure Europe Antidepressant Drugs Sales Volume Market Share by Type in 2017
Table Europe Antidepressant Drugs Sales Volume (MT) by Application (2013-2018)
Table Europe Antidepressant Drugs Sales Volume Market Share by Application (2013-2018)
Figure Europe Antidepressant Drugs Sales Volume Market Share by Application in 2017
Figure China Antidepressant Drugs Sales (MT) and Growth Rate (2013-2018)
Figure China Antidepressant Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Antidepressant Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table China Antidepressant Drugs Sales Volume (MT) by Players (2013-2018)
Table China Antidepressant Drugs Sales Volume Market Share by Players (2013-2018)
Figure China Antidepressant Drugs Sales Volume Market Share by Players in 2017
Table China Antidepressant Drugs Sales Volume (MT) by Type (2013-2018)
Table China Antidepressant Drugs Sales Volume Market Share by Type (2013-2018)
Figure China Antidepressant Drugs Sales Volume Market Share by Type in 2017
Table China Antidepressant Drugs Sales Volume (MT) by Application (2013-2018)
Table China Antidepressant Drugs Sales Volume Market Share by Application (2013-2018)
Figure China Antidepressant Drugs Sales Volume Market Share by Application in 2017
Figure Japan Antidepressant Drugs Sales (MT) and Growth Rate (2013-2018)
Figure Japan Antidepressant Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Antidepressant Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table Japan Antidepressant Drugs Sales Volume (MT) by Players (2013-2018)
Table Japan Antidepressant Drugs Sales Volume Market Share by Players (2013-2018)
Figure Japan Antidepressant Drugs Sales Volume Market Share by Players in 2017
Table Japan Antidepressant Drugs Sales Volume (MT) by Type (2013-2018)
Table Japan Antidepressant Drugs Sales Volume Market Share by Type (2013-2018)
Figure Japan Antidepressant Drugs Sales Volume Market Share by Type in 2017
Table Japan Antidepressant Drugs Sales Volume (MT) by Application (2013-2018)
Table Japan Antidepressant Drugs Sales Volume Market Share by Application (2013-2018)
Figure Japan Antidepressant Drugs Sales Volume Market Share by Application in 2017
Figure Southeast Asia Antidepressant Drugs Sales (MT) and Growth Rate (2013-2018)
Figure Southeast Asia Antidepressant Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Antidepressant Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table Southeast Asia Antidepressant Drugs Sales Volume (MT) by Players (2013-2018)
Table Southeast Asia Antidepressant Drugs Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Antidepressant Drugs Sales Volume Market Share by Players in 2017
Table Southeast Asia Antidepressant Drugs Sales Volume (MT) by Type (2013-2018)
Table Southeast Asia Antidepressant Drugs Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Antidepressant Drugs Sales Volume Market Share by Type in 2017
Table Southeast Asia Antidepressant Drugs Sales Volume (MT) by Application (2013-2018)
Table Southeast Asia Antidepressant Drugs Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Antidepressant Drugs Sales Volume Market Share by Application in 2017
Figure India Antidepressant Drugs Sales (MT) and Growth Rate (2013-2018)
Figure India Antidepressant Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Antidepressant Drugs Sales Price (USD/Kg) Trend (2013-2018)
Table India Antidepressant Drugs Sales Volume (MT) by Players (2013-2018)
Table India Antidepressant Drugs Sales Volume Market Share by Players (2013-2018)
Figure India Antidepressant Drugs Sales Volume Market Share by Players in 2017
Table India Antidepressant Drugs Sales Volume (MT) by Type (2013-2018)
Table India Antidepressant Drugs Sales Volume Market Share by Type (2013-2018)
Figure India Antidepressant Drugs Sales Volume Market Share by Type in 2017
Table India Antidepressant Drugs Sales Volume (MT) by Application (2013-2018)
Table India Antidepressant Drugs Sales Volume Market Share by Application (2013-2018)
Figure India Antidepressant Drugs Sales Volume Market Share by Application in 2017
Table Alkermes Basic Information List
Table Alkermes Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Alkermes Antidepressant Drugs Sales Growth Rate (2013-2018)
Figure Alkermes Antidepressant Drugs Sales Global Market Share (2013-2018)
Figure Alkermes Antidepressant Drugs Revenue Global Market Share (2013-2018)
Table Allergan Basic Information List
Table Allergan Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Allergan Antidepressant Drugs Sales Growth Rate (2013-2018)
Figure Allergan Antidepressant Drugs Sales Global Market Share (2013-2018)
Figure Allergan Antidepressant Drugs Revenue Global Market Share (2013-2018)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Bristol Myers Squibb Antidepressant Drugs Sales Growth Rate (2013-2018)
Figure Bristol Myers Squibb Antidepressant Drugs Sales Global Market Share (2013-2018
Figure Bristol Myers Squibb Antidepressant Drugs Revenue Global Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Eli Lilly Antidepressant Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly Antidepressant Drugs Sales Global Market Share (2013-2018)
Figure Eli Lilly Antidepressant Drugs Revenue Global Market Share (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Antidepressant Drugs Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Antidepressant Drugs Sales Global Market Share (2013-2018)
Figure GlaxoSmithKline Antidepressant Drugs Revenue Global Market Share (2013-2018)
Table Lundbeck Basic Information List
Table Lundbeck Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Lundbeck Antidepressant Drugs Sales Growth Rate (2013-2018)
Figure Lundbeck Antidepressant Drugs Sales Global Market Share (2013-2018
Figure Lundbeck Antidepressant Drugs Revenue Global Market Share (2013-2018)
Table Merck Basic Information List
Table Merck Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Merck Antidepressant Drugs Sales Growth Rate (2013-2018)
Figure Merck Antidepressant Drugs Sales Global Market Share (2013-2018)
Figure Merck Antidepressant Drugs Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Pfizer Antidepressant Drugs Sales Growth Rate (2013-2018)
Figure Pfizer Antidepressant Drugs Sales Global Market Share (2013-2018
Figure Pfizer Antidepressant Drugs Revenue Global Market Share (2013-2018)
Table Teva Basic Information List
Table Teva Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Teva Antidepressant Drugs Sales Growth Rate (2013-2018)
Figure Teva Antidepressant Drugs Sales Global Market Share (2013-2018)
Figure Teva Antidepressant Drugs Revenue Global Market Share (2013-2018)
Table Takeda Basic Information List
Table Takeda Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Takeda Antidepressant Drugs Sales Growth Rate (2013-2018)
Figure Takeda Antidepressant Drugs Sales Global Market Share (2013-2018)
Figure Takeda Antidepressant Drugs Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidepressant Drugs
Figure Manufacturing Process Analysis of Antidepressant Drugs
Figure Antidepressant Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antidepressant Drugs Major Players in 2017
Table Major Buyers of Antidepressant Drugs
Table Distributors/Traders List
Figure Global Antidepressant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Global Antidepressant Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Antidepressant Drugs Price (USD/Kg) and Trend Forecast (2018-2025)
Table Global Antidepressant Drugs Sales Volume (MT) Forecast by Regions (2018-2025)
Figure Global Antidepressant Drugs Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Antidepressant Drugs Sales Volume Market Share Forecast by Regions in 2025
Table Global Antidepressant Drugs Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Antidepressant Drugs Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Antidepressant Drugs Revenue Market Share Forecast by Regions in 2025
Figure United States Antidepressant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure United States Antidepressant Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Antidepressant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Europe Antidepressant Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure China Antidepressant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure China Antidepressant Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Antidepressant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Japan Antidepressant Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Antidepressant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Antidepressant Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Antidepressant Drugs Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure India Antidepressant Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Antidepressant Drugs Sales (MT) Forecast by Type (2018-2025)
Figure Global Antidepressant Drugs Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Antidepressant Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Antidepressant Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Antidepressant Drugs Price (USD/Kg) Forecast by Type (2018-2025)
Table Global Antidepressant Drugs Sales (MT) Forecast by Application (2018-2025)
Figure Global Antidepressant Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

抗うつ薬、大鬱病性障害、強迫神経症、全般性不安障害、パニック障害、三環系抗うつ薬、選択的セロトニン再取り込み阻害剤、セロトニン-ノルエピネフリン再取り込み阻害剤、モノアミンオキシダーゼ阻害剤、セロトニンアンタゴニスト・再取り込み阻害剤

★調査レポート[抗うつ薬の世界市場:販売動向2018] (コード:QYR80700922)販売に関する免責事項を必ずご確認ください。
★調査レポート[抗うつ薬の世界市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆